Sepicalm VG offers a novel mode of action with the dual benefit of the modulation of inflammation mediators and the reduction of the genetic expression of tyrosinase, a key pigmentation enzyme, at the early stage of melanogenesis. According to Seppic, it decreases cutaneous pigmentation induced by stress or through the aging process proven by in vitro and in vivo efficacy after two months of treatment. The ingredient can be incorporated up to 3% in all types of whitening, lightening and soothing products.
More info: www.seppic.com
Sepicalm VG Whitens, Lightens And Soothes the Skin
Published August 6, 2007
blog comments powered by Disqus